Critically, treatment with an IL-6R inhibitor (100 μg/dose, total 5 doses) significantly decreased liver metastases of ceramide-MeWo cells (Figures 5M and 5N), which indicates that stromal ceramide promotes melanoma liver metastasis via IL-6. The gene discussed is IL6R; the disease is melanoma.